Search

everythinglearnresearchcommunity

for

Search:↓

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Adrenal tumors can cause hair loss and high testosterone in women.

Postmenopausal virilization can be caused by ovarian hyperthecosis, treatable with surgery.

Progesterone may help trans women with breast development and health, but more research is needed.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Total testosterone levels can help diagnose androgen-producing tumors and hyperandrogenism in women.

The nano-carrier makes etoposide safer and more effective against lung cancer.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Treating hyperprolactinemia can help manage PCOS symptoms.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

A new mutation in the HR gene is linked to a rare form of hair loss with limb deformities.

CD34 is absent in most basal cell carcinoma cells but present in surrounding skin.

Oncogenic K-ras causes rapid cancerous changes in the mouth's lining.

Exercise-induced particles can slow breast cancer growth by boosting immune response.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Cells that move well may improve hair loss treatments by entering hair follicles.

Excessive male hormones in women cause symptoms like unwanted hair growth, and treatment requires careful medical evaluation.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Surgical removal of an adrenal tumor resolved hormonal issues in a young woman.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Recent findings advanced understanding of cancer mechanisms and potential treatments.

Some drugs linked to growth hormones may increase the chance of hair loss in women.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.